New Zealand markets close in 47 minutes

Ligand Pharmaceuticals Incorporated (LGND)

NasdaqGM - NasdaqGM Real-time price. Currency in USD
Add to watchlist
82.37-1.23 (-1.47%)
At close: 04:00PM EDT
82.37 0.00 (0.00%)
After hours: 04:20PM EDT
Show:
Income statement
Balance sheet
Annual

Cash flow

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
31/12/2019
Cash flows from operating activities
Net income
96,344
52,154
-33,361
57,138
-2,985
-
Depreciation & amortisation
34,909
35,643
51,370
50,946
27,966
-
Deferred income taxes
22,488
11,696
20,723
-8,618
-19,053
-
Stock-based compensation
27,146
25,743
60,285
38,783
30,727
-
Change in working capital
-34,056
-34,402
65,677
-57,004
-11,673
-
Accounts receivable
-238
-2,601
55,319
-28,616
-26,061
-
Inventory
-10,273
-10,870
12,058
-427
-17,799
-
Accounts payable
-
-4,704
-3,340
2,810
-1,245
-
Other working capital
-19,622
-4,272
119,927
70,037
50,128
-
Other non-cash items
194
2,449
5,872
-13,858
25,840
-
Net cash provided by operating activities
34,361
49,577
137,850
78,798
54,586
-
Cash flows from investing activities
Investments in property, plant and equipment
-53,983
-53,849
-17,923
-8,761
-4,458
-
Acquisitions, net
-26,652
-25,654
-750
0
-405,384
-
Purchases of investments
-164,534
-126,764
-51,226
-181,325
-422,523
-
Sales/maturities of investments
216,933
194,167
234,391
221,335
1,038,694
-
Other investing activities
-
-
-960
-1,220
1,900
-4,669
Net cash used for investing activities
-26,006
-11,682
163,624
30,523
231,648
-
Cash flows from financing activities
Debt repayment
-76,891
-76,899
-261,003
-164,948
-231,758
-
Common stock repurchased
-
-
0
0
-77,998
-453,048
Other financing activities
-4,458
-5,496
-18,219
-6,576
-3,806
-
Net cash used provided by (used for) financing activities
-46,990
-59,947
-275,990
-137,761
-310,545
-
Net change in cash
-38,635
-22,052
25,484
-28,440
-24,311
-
Cash at beginning of period
88,728
45,006
19,522
47,962
72,273
-
Cash at end of period
50,093
22,954
45,006
19,522
47,962
-
Free cash flow
Operating cash flow
34,361
49,577
137,850
78,798
54,586
-
Capital expenditure
-53,983
-53,849
-17,923
-8,761
-4,458
-
Free cash flow
-19,622
-4,272
119,927
70,037
50,128
-